Stone Capital is a Shanghai-based venture capital firm specializing in growth capital investments across technology, life sciences, and consumer sectors in China. The firm also provides private equity fund management services for entrepreneurs and family offices.
They made 1 investment in the last 12 months. Average disclosed round size is $283.5M (across 13 rounds with reported amounts).
Portfolio
13
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
16 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 LimX Dynamics | Series B | $200M | Jul 2026 |
 Iaso Biotherapeutics | Series C | $108M | Sep 2021 |
| MMGI | Series B | $1B | Jan 2020 |
| RRecBio | Series B | $227M | Jan 2020 |
| MMGI Tech | Series B | $1B | Jan 2020 |
 Smartmore | Series A | $100M | Jan 2020 |
 LandSpace | Series C | — | Jan 2020 |
 4Paradigm | Series C | $80M | Jan 2018 |
 Cailian Press | Series A | — | Jul 2015 |
| PPagoda | Series B | $230M | — |
| AAgilize | Unknown | $9M | — |
| Smartmore | Series B | $200M | — |
| LimX Dynamics | Growth | — | — |
| LimX Dynamics | Ipo | $200M | — |
 Jupiter Endovascular | Seed | $21M | — |
 DeepWay | Ipo | $310M | — |
Top Co-Investors
IDG Capital7 shared
Green Pine Capital Partners5 shared
HongShan4 shared
Future Fund3 shared
Sequoia Capital3 shared
CDH Investments2 shared
ZhenFund2 shared
GL Ventures1 shared
Plaisance Capital Management1 shared
JD.com1 shared
Alibaba Capital Partners1 shared
Source Code Capital1 shared
Shenzhen Capital Group1 shared
LYFE Capital1 shared
YuanBio Venture Capital1 shared
Legend Capital1 shared
AXA IM Alts1 shared
Cisco Investments1 shared
Luminous Ventures1 shared
Last updated: 20 October 2026